Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display

13P - Relationship of distress and quality of life with gut microbiome composition in newly diagnosed breast cancer patients: A prospective, observational study

Date

02 Dec 2023

Session

Poster Display

Presenters

Chi-Chan Lee

Citation

Annals of Oncology (2023) 34 (suppl_4): S1467-S1479. 10.1016/annonc/annonc1374

Authors

C. Lee1, P. Yang2, H. Yang3, C. Liu4, F. Lee1, W. Ko5, Y. Chang6

Author affiliations

  • 1 General Surgery, MMH - Mackay Memorial Hospital - Taipei Branch, 10449 - Taipei City/TW
  • 2 General Surgery, Mackay Memorial Hospital, 10449 - Taipei City/TW
  • 3 Division Of Molecular Medicine, Department Of Medical Research, Mackay Memorial Hospital - Tamsui Branch, 25160 - New Taipei City/TW
  • 4 Department Of Nursing, MMH - Mackay Memorial Hospital - Taipei Branch, 10449 - Taipei City/TW
  • 5 General Surgery, Hsinchu Mackay Memorial Hospital, 300 - Hsinchu City/TW
  • 6 Surgery Department, Mackay Memorial Hospital - Taipei Branch, 10449 - Taipei City/TW

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 13P

Background

There is little research about the stress, quality of life (QOL) and gut microbiota in newly diagnosed breast cancer patients.

Methods

The quality of life was evaluated by FACT-Breast questionnaire. The distress scale was evaluated by Distress Thermometer (Chinese version). All the fecal sample collection and FACT-Breast questionnaire and Distress Thermometer evaluation were performed on the first admission for breast cancer treatment. We sought to determine the relationship of distress scale and FACT-B different domain and fecal microbial composition among newly diagnosed breast cancer patients.

Results

Total 82 newly diagnosed breast cancer patients were enrolled in this prospective, observational study. The mean score of the FACT-B was 104.5 (SD, 19.76). The mean DT score was 4.43, with 53.7 % (44/82) of the patients reporting moderate to severe distress (score 5 or above). Several associations between distress, FACT-B different domain and microbial taxa were observed among this sample of breast cancer patients. Specifically, Alcaligenaceae and Sutterella were significantly more abundant in individuals with higher scores on the DT scale at the family and genus level, respectively (p=0.017), while Streptococcaceae (p=0.028) at the family level and Streptococcus (p=0.023) at the genus level were significantly more abundant in individuals with lower scores on the DT scale.

Conclusions

This study defines the relationships among stress, QOL and gut microbiota in newly diagnosed breast cancer patients and provides many useful information to find potential probiotics for decreasing stress and improving QOL in breast cancer patients.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

P-S. Yang.

Funding

This study was supported by grants from the National Science and Technology Council, Taiwan (NSTC 110-2321-B-195-002) and MacKay Memorial Hospital (MMH-109-86), Taipei, Taiwan.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.